For journalists, medical partners and publications. Editorial press material. Last updated: October 2026.
Presentation in 40 words
NostraBiome is a Romanian medical technology company that develops customized AI biological models. The platform integrates molecular, clinical and daily data to understand the body's evolution and support continuous care alongside the physician.
Editorial presentation
Modern medicine produces huge amounts of information about the human body, but most of it is interpreted separately: a blood test, a genetic result, a diagnosis, a consultation. In between, biology continues to change, and information about how the patient responds to treatment, diet, sleep, and stress often remains fragmented or unused.
NostraBiome is building a technological alternative: AI biological models that preserve a person's context, aggregate their data, and track how the body's condition changes over time. The goal is to move from predominantly reactive medicine based on isolated episodes to more continuous, personalized and, where possible, preventive care.
Nostra does not replace the doctor. Diagnosis, treatment and clinical decisions remain the responsibility of the medical team.
1. The new frontier: AI models for biology
Linguistic models have shown that AI can learn complex relationships from large volumes of information. In biology, the challenge is different: the body is not a static collection of documents, but a dynamic system, where metabolism, immunity, the microbiome, genetics, behavior and treatments interact.
NostraBiome develops what it calls frontier biology models: models oriented to the individual biological state and its evolution. The ambition is not just to answer questions about an outcome, but to build a longitudinal representation of the person, updated as new data emerges.
2. Why the Nostra models are different
Multi-modal context. Bring together blood work, medical history, symptoms, treatments, microbiome, genetics, and when available, data from wearable devices.
Longitudinal memory. A value is not only interpreted through a reference interval, but also relative to the person's history and changes.
Learning loop. The model follows the sequence: understand the state → propose priorities → observe the response → update the context → adapt the guidance.
Systems Biology. Does not treat the microbiome, metabolism, and immune system as independent islands; look for relationships between them without assuming that any association is causal.
Link to medical practice. The goal is for the doctor to see not only the photo of a consultation, but also the evolution between consultations.
3. LIFE OS: an operating system for changing biology
LIFE OS is NostraBiome's architectural vision for a persistent biological model: a system that integrates molecular, clinical, behavioral and sensor signals, estimates current state, tracks trajectory and learns from observed responses.
Rather than treating each test as an independent event, LIFE OS attempts to create continuity between observation, recommendation, and reassessment. The term "operating system" is an analogy for software architecture, not a claim that it can autonomously control human biology.
4. Forgotten data: from medical photos to trajectories
Much of what matters to health happens between appointments: how a meal was tolerated, how symptoms changed after an intervention, what happened to sleep, energy or metabolic markers. These signals are often lost, uncorrelated or impossible to analyze retrospectively.
Nostra aims to turn this scattered information into a usable biological history. A systems engineering analogy is useful: you can't understand the behavior of a complex system from just two screenshots; you need observations over time, context and feedback.
5. DeepGene: a molecular input, not the whole product
DeepGene adds microbiome and human DNA information to the individual model, complementing clinical analysis and everyday data. Molecular testing is a source of signals, not a substitute for consultation or a universal diagnosis. The exact test specifications and analytical limits are described according to the current technical documentation.
6. Medical device and clinical trials
NostraBiome presents on its website a medical device software with CE mark, class I, under EU Regulation 2017/745 (MDR), with EUDAMED registration RO-MF-000044337 and ANMDMR reference RO_I_105_298/10.12.2024. The CE marking certifies the conformity of the mentioned product, in its field of use; it is not a blanket validation of all efficacy claims, all portfolio products, or future features.
The company lists more than 1,000 patients in clinical trials, five studies conducted and four published results on its website. The full list of studies—with design, populations, endpoints, outcomes, and limitations—is available upon request for editorial review.
Cited publication: 10.3390/ijms27010201. The results of a study should not be extrapolated to all medical indications or to all LIFE OS functionalities.
7. Two ways to apply the same vision
NostraBiome — continuous care for complex needs
For digestive health, oncology support, metabolic health, GLP-1 treatments and other complex situations, NostraBiome tracks the patient's progress within the context of the existing medical plan. nostrabiome.com
Nostra Health — prevention and everyday health
Nostra Health brings the same longitudinal approach to audiences interested in prevention, longevity and optimization. The website describes an annual membership with more than 42 biomarkers, blood tests at participating Regina Maria centers, selective retesting every six months and daily guidance based on personal data. nostra.health
Nostra Health should not be presented as a tool that guarantees disease prevention. It is an information and guidance experience that does not replace medical decisions.
8. Why this change matters
The fundamental question is no longer just "what do my tests show today?", but "how is my body changing, what influences these changes, and what should I watch next?". For NostraBiome, the future of care means connecting the consultation with real life without eliminating the role of the clinician.
9. Editorial assignments and interviews
- Can AI build an individual biological model, not just interpret test results?
- Why does episodic medicine lose information about the patient's evolution?
- What differentiates a longitudinal biological model from a medical chatbot?
- Microbiome and DNA: what information do they bring and where are their limits?
- How do we rigorously evaluate clinical evidence for AI-based medical software?
- How can prevention become a continuous process, not an annual check?
10. Resources for Journalists
Website: nostrabiome.com
Preventive health: nostra.health
Science: nostrabiome.com/science
Publication: doi.org/10.3390/ijms27010201
Contact: cp@nostrabiome.com
Materials available upon request: logo and visual identity, photos of founders and team, compliance document with exact scope of use, and full table of studies with DOIs and limitations.
